Skip to content
← Back to this collection

PUBLICATIONS · 16569462

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lung Cancer
Publication date
2006 May
First author
Brodowicz T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Brodowicz T
      type
      Author
    2. name
      Krzakowski M
      type
      Author
    3. name
      Zwitter M
      type
      Author
    4. name
      Tzekova V
      type
      Author
    5. name
      Ramlau R
      type
      Author
    6. name
      Ghilezan N
      type
      Author
    7. name
      Ciuleanu T
      type
      Author
    8. name
      Cucevic B
      type
      Author
    9. name
      Gyurkovits K
      type
      Author
    10. name
      Ulsperger E
      type
      Author
    11. name
      Jassem J
      type
      Author
    12. name
      Grgic M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Brodowicz T
      type
      Author
    2. name
      Krzakowski M
      type
      Author
    3. name
      Zwitter M
      type
      Author
    4. name
      Tzekova V
      type
      Author
    5. name
      Ramlau R
      type
      Author
    6. name
      Ghilezan N
      type
      Author
    7. name
      Ciuleanu T
      type
      Author
    8. name
      Cucevic B
      type
      Author
    9. name
      Gyurkovits K
      type
      Author
    10. name
      Ulsperger E
      type
      Author
    11. name
      Jassem J
      type
      Author
    12. name
      Grgic M
      type
      Author
    bibliography ids
    1. nci-bib-91a4830e28972e69ae8103d0
    book metadata
    content sha256
    9ea606819ad2b867d796d3065202545d702f1366db08117685c8712bbbe30a53
    document type
    citation
    dois
    1. 10.1016/j.lungcan.2006.01.006
    electronic publication date
    display
    2006 Mar 29
    precision
    day
    year
    2006
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:16569462
    immutable id
    pubmed:16569462@9ea606819ad2b867d796d3065202545d702f1366db08117685c8712bbbe30a53
    journal
    abbreviation
    Lung Cancer
    issn electronic
    Source null
    issn print
    0169-5002
    issue
    2
    name
    Lung cancer (Amsterdam, Netherlands)
    nlm unique id
    8800805
    pages
    155-63
    volume
    52
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      16569462
      provenance
      batch id
      19fb2de9a00882c94e86
      provider
      NCBI PubMed ESummary
      record sha256
      1351d0a7fbb15704f336ad4b612887bc45a91050ba650391cbe252e9c7a77c19
      response sha256
      4c446464d8fd06bff771a2bb5f3529ef4abe372e3c19f6fb7223068d839a263d
      retrieved at
      2026-09-09T23:46:06.810486+00:00
      publication date
      display
      2006 May
      precision
      month
      year
      2006
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/16569462/
      title
      Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial.

      Preserved source evidence · Not medical advice